| Symbol |
Name |
Standardized Value |
|
THPO
|
thrombopoietin
|
3.075
|
|
F2
|
coagulation factor II (thrombin)
|
2.762
|
|
ALB
|
albumin
|
2.568
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
2.538
|
|
AFP
|
alpha-fetoprotein
|
2.217
|
|
EPO
|
erythropoietin
|
2.205
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
2.18
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
2.108
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
2.05
|
|
HBE1
|
hemoglobin, epsilon 1
|
1.986
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.94
|
|
CRP
|
C-reactive protein, pentraxin-related
|
1.935
|
|
CD4
|
CD4 molecule
|
1.93
|
|
VWF
|
von Willebrand factor
|
1.918
|
|
HP
|
haptoglobin
|
1.915
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
1.915
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
1.91
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.909
|
|
HAMP
|
hepcidin antimicrobial peptide
|
1.902
|
|
JAK2
|
Janus kinase 2
|
1.894
|
|
CD8A
|
CD8a molecule
|
1.887
|
|
CP
|
ceruloplasmin (ferroxidase)
|
1.843
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
1.806
|
|
IFNA1
|
interferon, alpha 1
|
1.745
|
|
IL6
|
interleukin 6
|
1.743
|
|
LCOR
|
ligand dependent nuclear receptor corepressor
|
1.706
|
|
SLC37A4
|
solute carrier family 37 (glucose-6-phosphate transporter), member 4
|
1.694
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
1.693
|
|
TNF
|
tumor necrosis factor
|
1.684
|
|
CD34
|
CD34 molecule
|
1.658
|
|
BCHE
|
butyrylcholinesterase
|
1.658
|
|
CD68
|
CD68 molecule
|
1.632
|
|
IFNG
|
interferon, gamma
|
1.623
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
1.618
|
|
IFNA2
|
interferon, alpha 2
|
1.614
|
|
UROS
|
uroporphyrinogen III synthase
|
1.604
|
|
CD2
|
CD2 molecule
|
1.593
|
|
IFNA16
|
interferon, alpha 16
|
1.592
|
|
IFNA14
|
interferon, alpha 14
|
1.591
|
|
IFNA8
|
interferon, alpha 8
|
1.591
|
|
IFNA10
|
interferon, alpha 10
|
1.591
|
|
IFNA21
|
interferon, alpha 21
|
1.591
|
|
IFNA7
|
interferon, alpha 7
|
1.591
|
|
IFNA6
|
interferon, alpha 6
|
1.59
|
|
IFNA5
|
interferon, alpha 5
|
1.589
|
|
IFNA13
|
interferon, alpha 13
|
1.588
|
|
IFNA4
|
interferon, alpha 4
|
1.586
|
|
IFNA17
|
interferon, alpha 17
|
1.579
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.57
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.57
|
|
PF4
|
platelet factor 4
|
1.566
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
1.551
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.538
|
|
IL10
|
interleukin 10
|
1.531
|
|
ALDH18A1
|
aldehyde dehydrogenase 18 family, member A1
|
1.52
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
1.518
|
|
CD19
|
CD19 molecule
|
1.493
|
|
ACE
|
angiotensin I converting enzyme
|
1.484
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.476
|
|
SST
|
somatostatin
|
1.476
|
|
CD5
|
CD5 molecule
|
1.464
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
1.431
|
|
HBB
|
hemoglobin, beta
|
1.428
|
|
THBD
|
thrombomodulin
|
1.427
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.425
|
|
IL1B
|
interleukin 1, beta
|
1.42
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
1.405
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
1.4
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.393
|
|
IL2
|
interleukin 2
|
1.385
|
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
1.382
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
1.376
|
|
F8
|
coagulation factor VIII, procoagulant component
|
1.366
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
1.354
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
1.346
|
|
CD1E
|
CD1e molecule
|
1.33
|
|
CD1D
|
CD1d molecule
|
1.321
|
|
CALR
|
calreticulin
|
1.32
|
|
CD1A
|
CD1a molecule
|
1.32
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
1.319
|
|
LRBA
|
LPS-responsive vesicle trafficking, beach and anchor containing
|
1.315
|
|
CD1B
|
CD1b molecule
|
1.312
|
|
CD38
|
CD38 molecule
|
1.305
|
|
IL11
|
interleukin 11
|
1.296
|
|
PF4V1
|
platelet factor 4 variant 1
|
1.296
|
|
IL1A
|
interleukin 1, alpha
|
1.281
|
|
TFRC
|
transferrin receptor
|
1.262
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.25
|
|
NAAA
|
N-acylethanolamine acid amidase
|
1.249
|
|
PLG
|
plasminogen
|
1.249
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.248
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
1.244
|
|
MME
|
membrane metallo-endopeptidase
|
1.24
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.235
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.234
|
|
CD1C
|
CD1c molecule
|
1.232
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
1.227
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
1.218
|
|
FBL
|
fibrillarin
|
1.218
|
|
CD163
|
CD163 molecule
|
1.213
|
|
PSAP
|
prosaposin
|
1.211
|
|
IL3
|
interleukin 3
|
1.207
|
|
CD22
|
CD22 molecule
|
1.207
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
1.203
|
|
NPHP3
|
nephronophthisis 3 (adolescent)
|
1.198
|
|
CD27
|
CD27 molecule
|
1.194
|
|
HFE
|
hemochromatosis
|
1.189
|
|
RUNX1
|
runt-related transcription factor 1
|
1.189
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.181
|
|
INS
|
insulin
|
1.181
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
1.181
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.18
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.178
|
|
IL4
|
interleukin 4
|
1.174
|
|
TFR2
|
transferrin receptor 2
|
1.173
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
1.172
|
|
CD207
|
CD207 molecule, langerin
|
1.168
|
|
CD7
|
CD7 molecule
|
1.166
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
1.157
|
|
SPX
|
spexin hormone
|
1.155
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
1.15
|
|
HJV
|
hemojuvelin BMP co-receptor
|
1.144
|
|
TLR4
|
toll-like receptor 4
|
1.139
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
1.132
|
|
PLAT
|
plasminogen activator, tissue
|
1.129
|
|
RHD
|
Rh blood group, D antigen
|
1.127
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.125
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
1.121
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
1.119
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
1.116
|
|
EPB42
|
erythrocyte membrane protein band 4.2
|
1.111
|
|
KITLG
|
KIT ligand
|
1.104
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.098
|
|
SPN
|
sialophorin
|
1.097
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
1.091
|
|
IL17A
|
interleukin 17A
|
1.089
|
|
MPO
|
myeloperoxidase
|
1.088
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
1.081
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
1.074
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
1.071
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.07
|
|
IL18
|
interleukin 18
|
1.069
|
|
POLR2L
|
polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa
|
1.068
|
|
GOLM1
|
golgi membrane protein 1
|
1.064
|
|
TMEM67
|
transmembrane protein 67
|
1.061
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.059
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.057
|
|
B2M
|
beta-2-microglobulin
|
1.051
|
|
IFNL3
|
interferon, lambda 3
|
1.038
|
|
EDN1
|
endothelin 1
|
1.033
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
1.031
|
|
EPOR
|
erythropoietin receptor
|
1.026
|
|
DZIP1L
|
DAZ interacting zinc finger protein 1-like
|
1.024
|
|
PTH
|
parathyroid hormone
|
1.022
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.021
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.019
|
|
ETV6
|
ets variant 6
|
1.017
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
1.016
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
1.005
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
1.003
|
|
SETBP1
|
SET binding protein 1
|
1.0
|
